Automated acute pulmonary embolism detection and staging from CT

NIH RePORTER · NIH · R43 · $291,369 · view on reporter.nih.gov ↗

Abstract

Project Summary / Abstract Minnesota HealthSolutions (MHS) proposes a Phase I project to develop and validate a software product capable of automatically detecting and staging pulmonary embolisms (PEs) using clinically routine pulmonary CT angiograms (CTAs). The proposed system will combine state-of-the-art machine learning methods and the clinical expertise of MEDNAX Radiology into a system that integrates seamlessly into the Radiology workflow and standard patient care path to improve the treatment decisions of physicians in the emergency department. Pulmonary embolism is the third most common cause of death in hospital patients with an estimated incidence of 1 per 1,000 patients. CTAs are routinely used to detect PE today; however, there is significant variability in the detection rate among radiologists using CTA. Furthermore, despite the strong evidence that the RV/LV ratio is an important clinical biomarker it is rarely measured quantitatively in practice. A successful completion of this project would provide a workflow-integrated tool capable of faster PE detection and more accurate staging of right heart strain to guide the physician’s treatment decision.

Key facts

NIH application ID
10008093
Project number
1R43HL152825-01
Recipient
MINNESOTA HEALTHSOLUTIONS CORPORATION
Principal Investigator
Ryan M Chamberlain
Activity code
R43
Funding institute
NIH
Fiscal year
2020
Award amount
$291,369
Award type
1
Project period
2020-05-20 → 2022-01-14